The Global Pharmacovigilance Market Share is being driven by escalated awareness in the public health sector along with rise in preference for safe medicines. Number of national pharmacovigilance centers is increasing which is playing an imperative role in aiding the market. Besides that, pharmacovigilance is experiencing various challenges to develop improved healthcare system. The factor that restrain the market growth is unavailability of unskilled labor and data about drugs collected via the web. However, rigorous pharmacovigilance activities, if mandated may expand global Pharmacovigilance market size, encouraging it touch up to USD xx.xx Billion by the end of 2025. The growth rate was steady in 2018, growing with an optimistic CAGR of x.x% during the forecast period.
Request a sample of this report @ https://www.adroitmarketresearch.com/contacts/request-sample/687
Based on regional segmentation, North America ranks highest in the global pharmacovigilance market because of high regulatory compliance and incidences of adverse drug reactions for pharmacovigilance. In addition to that, abundant biotechnology and pharmaceutical companies, is propelling regional market growth. Asia-Pacific considered fastest growing region of global pharmacovigilance market as there are higher incidences of adverse drug reactions, rising concern for efficacy and drug safety, and toxicity, and growing number of biotechnology and pharmaceuticals companies. Moreover, the pharmacovigilance market is rapidly growing because of high growth of generic drugs market in emerging economies like India and China.
The global Pharmacovigilance industry is segmented on the basis of methods, clinical trial phase, applications, end-user, region and service providers. Based on different phases of clinical trial, the market has several categories which include phase I clinical trial, phase II clinical trial, phase III clinical trial, and phase IV clinical trial. The leading segment is phase IV clinical trial segment, carrying largest global Pharmacovigilance market share of 75.2% in 2017.
Pharmacovigilance is essential as safety surveillance post drug is sold to patients. It finds and reports ADRs and damaging effects when drugs are discontinued or restricted in use. Phase IV pharmacovigilance may impact badly on business or company’s financial performance. Therefore, growing number of pharmaceutical companies and higher number of medicines favor the market growth. Preclinical trial will have positive growth due to accelerating number of novel drug developments by biotech and pharma companies across the world. Preclinical trial are essential part of drug development and drug assessment. Thus, growing demand for targeted therapies owe to higher number of diseases.
On the basis of pharmacovigilance methods, the global Pharmacovigilance industry is classified as targeted spontaneous reporting, spontaneous reporting, electronic health record mining, intensified adverse drug reaction reporting and cohort event monitoring. In terms of service providers, the global pharmacovigilance market is bifurcated into contract outsourcing pharmacovigilance and in-house pharmacovigilance. Leading segment is contract outsourcing pharmacovigilance and is anticipated to grow at a higher rate in the next couple of years.
Browse the complete report @ https://www.adroitmarketresearch.com/industry-reports/pharmacovigilance-market
Some of the main players operating in the global Pharmacovigilance market include Sanofi, Accenture, Cognizant Technology Solutions, Clinquest Group B.V., Wipro Limited, ICON plc, PAREXEL International Corporation, F. Hoffmann-La Roche Ltd., Novartis AG, iGATE Corporation, Pfizer Inc., Bristol-Myers Squibb Company and GlaxoSmithKline.
Key segments of ‘Global Pharmacovigilance Market’
Based on end-use, the market has been segmented into,
Based on type of method, the market has been segmented into,
Targeted Spontaneous Reporting
Cohort Event Monitoring
Intensified ADR Reporting
Based on region, the market has been segmented into,
Middle East and Africa
What to expect from the upcoming report on ‘Global Pharmacovigilance Market’:
– Future prospects and current trends of the global pharmacovigilance market by the end of forecast period (2018-2025)
– Information regarding technological progressions as well as innovations taking place in developing economies
– Supportive initiatives by government likely to influence the market dynamics
– Trends, drivers, opportunities, restraints, challenges and key developments in the market
– In-depth analysis of different market segmentations including regional segmentations, and product types
– Deep analysis about the competitive landscape of the market and the initiatives by them to improve this market
Who should buy this report?
Venture capitalists, Investors, financial institutions, Analysts, Government organizations, regulatory authorities, policymakers, researchers, strategy managers, and academic institutions looking for insights into the market to determine future strategies.
Pre-book the research study on Pharmacovigilance and Get Flat 10% Discount @ https://www.adroitmarketresearch.com/researchreport/purchase/687
Adroit Market Research is an India-based business analytics and consulting company incorporated in 2018. Our target audience is a wide range of corporations, manufacturing companies, product/technology development institutions and industry associations that require understanding of a market’s size, key trends, participants and future outlook of an industry. We intend to become our clients’ knowledge partner and provide them with valuable market insights to help create opportunities that increase their revenues. We follow a code– Explore, Learn and Transform. At our core, we are curious people who love to identify and understand industry patterns, create an insightful study around our findings and churn out money-making roadmaps.
Adroit Market Research
3131 McKinney Ave Ste 600,
Dallas, Texas – 75204, U.S.A
Phone No: +1 (214) 884-6068
Email: [email protected]